nexiclon xr

Generic: clonidine

Labeler: athena bioscience, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name nexiclon xr
Generic Name clonidine
Labeler athena bioscience, llc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

clonidine .17 mg/1

Manufacturer
Athena Bioscience, LLC

Identifiers & Regulatory

Product NDC 71511-503
Product ID 71511-503_dad34ef3-06d2-6355-e053-2995a90aee5f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022500
Listing Expiration 2026-12-31
Marketing Start 2022-03-01

Pharmacologic Class

Established (EPC)
central alpha-2 adrenergic agonist [epc]
Mechanism of Action
adrenergic alpha2-agonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71511503
Hyphenated Format 71511-503

Supplemental Identifiers

RxCUI
885880 1050338
UNII
MN3L5RMN02
NUI
N0000009918 N0000175554

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nexiclon xr (source: ndc)
Generic Name clonidine (source: ndc)
Application Number NDA022500 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .17 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71511-503-30)
source: ndc

Packages (1)

71511-503-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71511-503-30)

Ingredients (1)

clonidine (.17 mg/1)

Linked Drug Pages (1)

Nexiclon XR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "dad34ef3-06d2-6355-e053-2995a90aee5f", "openfda": {"nui": ["N0000009918", "N0000175554"], "unii": ["MN3L5RMN02"], "rxcui": ["885880", "1050338"], "spl_set_id": ["dad35a6f-d57e-f302-e053-2995a90a9efb"], "pharm_class_epc": ["Central alpha-2 Adrenergic Agonist [EPC]"], "pharm_class_moa": ["Adrenergic alpha2-Agonists [MoA]"], "manufacturer_name": ["Athena Bioscience, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71511-503-30)", "package_ndc": "71511-503-30", "marketing_start_date": "20220301"}], "brand_name": "Nexiclon XR", "product_id": "71511-503_dad34ef3-06d2-6355-e053-2995a90aee5f", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "71511-503", "generic_name": "Clonidine", "labeler_name": "Athena Bioscience, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nexiclon XR", "active_ingredients": [{"name": "CLONIDINE", "strength": ".17 mg/1"}], "application_number": "NDA022500", "marketing_category": "NDA", "marketing_start_date": "20220301", "listing_expiration_date": "20261231"}